CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
IFI27 |
P40305
|
interferon alpha inducible protein 27
|
|
1.1E-02 |
0.437 |
0.769 |
TOP2A |
P11388
|
DNA topoisomerase II alpha
|
|
0.99 |
0.497 |
0.731 |
ZNRD2 |
O60232
|
zinc ribbon domain containing 2
|
|
1.8E-07 |
0.443 |
0.769 |
TICAM2 |
Q86XR7 Q9Y3B3
|
toll like receptor adaptor molecule 2
|
|
2.6E-03 |
0.438 |
0.769 |
TMED7-TICAM2 |
Q86XR7 Q9Y3B3
|
TMED7-TICAM2 readthrough
|
|
2.6E-03 |
0.438 |
0.769 |
H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
DCTN6 |
O00399
|
dynactin subunit 6
|
Cellular structure
|
5.6E-02 |
0.442 |
0.769 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
HGF |
P14210
|
hepatocyte growth factor
|
Enzyme
|
1.00 |
0.374 |
0.885 |
PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
PSMD9 |
O00233
|
proteasome 26S subunit, non-ATPase 9
|
Enzyme modulator
|
4.9E-06 |
0.435 |
0.846 |
BECN1 |
Q14457
|
beclin 1
|
Enzyme modulator
|
0.94 |
0.432 |
0.846 |
BRD4 |
O60885
|
bromodomain containing 4
|
Epigenetic regulator
|
1.00 |
0.446 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
ERBB4 |
Q15303
|
erb-b2 receptor tyrosine kinase 4
|
Kinase
|
1.00 |
0.455 |
0.846 |